- Home
- SBET vs ONCO Comparison
SBET vs ONCO Comparison
Compare SBET & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBET
- ONCO
- Stock Information
- Founded
- SBET 1995
- ONCO 2018
- Country
- SBET United States
- ONCO United States
- Employees
- SBET N/A
- ONCO N/A
- Industry
- SBET Computer Software: Prepackaged Software
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- SBET Technology
- ONCO Health Care
- Exchange
- SBET Nasdaq
- ONCO Nasdaq
- Market Cap
- SBET 1.8M
- ONCO 1.8M
- IPO Year
- SBET 1997
- ONCO 2022
- Fundamental
- Price
- SBET $40.14
- ONCO $0.07
- Analyst Decision
- SBET
- ONCO
- Analyst Count
- SBET 0
- ONCO 0
- Target Price
- SBET N/A
- ONCO N/A
- AVG Volume (30 Days)
- SBET 5.7M
- ONCO 44.3M
- Earning Date
- SBET 05-15-2025
- ONCO 06-17-2025
- Dividend Yield
- SBET N/A
- ONCO N/A
- EPS Growth
- SBET N/A
- ONCO N/A
- EPS
- SBET N/A
- ONCO N/A
- Revenue
- SBET $3,428,134.00
- ONCO $2,524,116.00
- Revenue This Year
- SBET N/A
- ONCO N/A
- Revenue Next Year
- SBET N/A
- ONCO N/A
- P/E Ratio
- SBET N/A
- ONCO N/A
- Revenue Growth
- SBET N/A
- ONCO 4217.31
- 52 Week Low
- SBET $2.26
- ONCO $0.05
- 52 Week High
- SBET $124.12
- ONCO $14.00
- Technical
- Relative Strength Index (RSI)
- SBET 57.71
- ONCO 45.72
- Support Level
- SBET $45.61
- ONCO $0.07
- Resistance Level
- SBET $82.70
- ONCO $0.09
- Average True Range (ATR)
- SBET 17.07
- ONCO 0.01
- MACD
- SBET 2.08
- ONCO 0.00
- Stochastic Oscillator
- SBET 32.15
- ONCO 25.67
About SBET SharpLink Gaming Ltd.
SharpLink Gaming Inc is a online technology company that connects sports fans, leagues and sports websites to relevant and timely sports betting content. The company owns a performance marketing platform through which the company owns and operates state-specific web domains designed to attract, acquire, and drive local sports betting and casino traffic directly to its sportsbook and casino partners which are licensed to operate in each respective state. The company has one operating segment: Affiliate Marketing Services, which operates in United States and Rest of the world. The company generates the majority of the revenue earned from the Affiliate Marketing Services in Rest of the world.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.